With 0.99 million shares traded, the volume of ECG (ECG) remained well above its average of 0.5 million shares, signaling heightened investor interest. During the latest trading session, the Engineering & Construction firm within the broader Industrials sector saw its stock price hit a session high of $98.01 and a low of $89.82.
Over the past 52 weeks, ECG has ranged between a low of $31.38 and a high of $95.90, while its 1-year price target currently stands at $95.67. The stock’s beta of 3.84 indicates higher volatility compared to the overall market.
Price Performance and Earnings
Stock performance remains a crucial indicator for potential investors. ECG has demonstrated impressive momentum, gaining 1.46% in the past week, 12.90% over the past month, and an impressive 30.41% in the last three months. Over six months, the stock has soared 100.21%, marking a 41.87% gain year-over-year and 77.71% growth year-to-date.
The trailing 12-month EPS stands at 3.54, with analysts forecasting 3.48 for the next year and 0.62 for the upcoming quarter. These projections suggest EPS growth of 12.46% for the current year and 10.12% for the next.
Float and Short Interest
ECG currently has 51.01 million shares outstanding and a float of 50.83 million available for public trading. As of October 15, 2025, short interest reached 1.88 million shares, marking a significant increase from previous periods.
The company’s leadership includes Mr. Jeffrey S. Thiede, serving as President, CEO & Director, and Mr. Maximillian J. Marcy, as VP, CFO & Treasurer.
Financial Overview
Sound investment decisions rely on strong fundamentals. In its fiscal quarter ended June 30, 2025, ECG reported $921.47 million in revenue and $72.51 million in operating income. The company also posted EBITDA of $81.54 million and diluted EPS of $1.03, underscoring consistent financial performance.
Analyst Ratings and Target Price
Analysts remain optimistic on ECG’s outlook, with target prices ranging from $94.00 (low) to $105.00 (high) and an average of $100.33. Based on these projections, ECG could see upside potential of 12.56% to reach the high target, or 0.77% at the low end. The average target implies a 7.56% potential rise from current levels.
EPS: Estimates vs. Actual
Earnings estimates provide valuable insights into ECG’s growth trajectory. Analysts project yearly EPS between $2.70512 (low) and $2.88028 (high), averaging $2.7927. The company’s prior quarter delivered a positive earnings surprise of $0.59. For the next quarter, the average EPS estimate stands at $0.73, aligning with both the high and low projections.
In Summary:
ECG’s strong trading volume, rising price momentum, and bullish analyst outlook position it as a stock to watch within the Industrials sector. With improving earnings performance and solid financial fundamentals, investors appear confident in the company’s continued upward trajectory.